Twenty
studies
on
gut
microbiota
in
PD
have
been
reported,
whereas
only
one
study
has
reported
iRBD
from
Germany.
the
highest
likelihood
ratio
to
develop
PD.
Our
meta-analysis
of
Japan
and
Germany
revealed
increased
mucin-layer-degrading
genus
Akkermansia
iRBD.
Nutrients,
Год журнала:
2021,
Номер
13(6), С. 2099 - 2099
Опубликована: Июнь 19, 2021
Emerging
evidence
indicates
that
gut
microbiota
is
important
in
the
regulation
of
brain
activity
and
cognitive
functions.
Microbes
mediate
communication
among
metabolic,
peripheral
immune,
central
nervous
systems
via
microbiota–gut–brain
axis.
However,
it
not
well
understood
how
microbiome
neurons
mutually
interact
or
these
interactions
affect
normal
functioning
cognition.
We
summarize
mechanisms
whereby
regulate
production,
transportation,
neurotransmitters.
also
discuss
dysbiosis
affects
function,
especially
neurodegenerative
diseases
such
as
Alzheimer’s
disease
Parkinson’s
disease.
Pharmacological Research,
Год журнала:
2021,
Номер
172, С. 105840 - 105840
Опубликована: Авг. 24, 2021
Emerging
evidence
indicates
that
the
gut
microbiota
play
a
crucial
role
in
bidirectional
communication
between
and
brain
suggesting
microbes
may
shape
neural
development,
modulate
neurotransmission
affect
behavior,
thereby
contribute
to
pathogenesis
and/or
progression
of
many
neurodevelopmental,
neuropsychiatric,
neurological
conditions.
This
review
summarizes
recent
data
on
microbiota-gut-brain
axis
pathophysiology
neuropsychiatric
disorders
including
depression,
anxiety,
schizophrenia,
autism
spectrum
disorders,
Parkinson's
disease,
migraine,
epilepsy.
Also,
involvement
co-existing
with
conditions
is
highlighted.
We
discuss
from
both
vivo
preclinical
experiments
clinical
reports
including:
(1)
studies
germ-free
animals,
(2)
exploring
composition
animal
models
diseases
or
humans,
(3)
evaluating
effects
probiotic,
prebiotic
antibiotic
treatment
as
well
(4)
fecal
transplantation.
Nature Communications,
Год журнала:
2022,
Номер
13(1)
Опубликована: Ноя. 15, 2022
Abstract
Parkinson’s
disease
(PD)
may
start
in
the
gut
and
spread
to
brain.
To
investigate
role
of
microbiome,
we
conducted
a
large-scale
study,
at
high
taxonomic
resolution,
using
uniform
standardized
methods
from
end.
We
enrolled
490
PD
234
control
individuals,
deep
shotgun
sequencing
fecal
DNA,
followed
by
metagenome-wide
association
studies
requiring
significance
two
(ANCOM-BC
MaAsLin2)
declare
association,
network
analysis
identify
polymicrobial
clusters,
functional
profiling.
Here
show
that
over
30%
species,
genes
pathways
tested
have
altered
abundances
PD,
depicting
widespread
dysbiosis.
PD-associated
species
form
clusters
grow
or
shrink
together,
some
compete.
microbiome
is
permissive,
evidenced
overabundance
pathogens
immunogenic
components,
dysregulated
neuroactive
signaling,
preponderance
molecules
induce
alpha-synuclein
pathology,
over-production
toxicants;
with
reduction
anti-inflammatory
neuroprotective
factors
limiting
capacity
recover.
validate,
human
findings
were
observed
experimental
models;
reconcile
resolve
literature;
provide
broad
foundation
wealth
concrete
testable
hypotheses
discern
PD.
Journal of Advanced Research,
Год журнала:
2021,
Номер
38, С. 223 - 244
Опубликована: Сен. 17, 2021
Recent
research
on
the
implications
of
gut
microbiota
brain
functions
has
helped
to
gather
important
information
relationship
between
them.
Pathogenesis
neurological
disorders
is
found
be
associated
with
dysregulation
gut-brain
axis.
Some
bacteria
metabolites
are
directly
increase
in
reactive
oxygen
species
levels,
one
most
risk
factors
neurodegeneration.
Besides
their
morbid
association,
also
play
a
significant
role
reducing
onset
these
life-threatening
disorders.Studies
done
recent
past
raises
two
link
and
brain:
"gut
microbiota-oxidative
stress-neurodegeneration"
microbiota-antioxidant-neuroprotection.
This
review
aims
gives
deep
insight
our
readers,
collective
studies
done,
focusing
mediated
oxidative
stress
involved
neurodegeneration
along
focus
those
showing
involvement
neuroprotection.This
focused
three
main
key
concepts.
Firstly,
mounting
evidences
from
clinical
preclinical
arenas
shows
influence
resulting
dysfunctional
processes.
Therefore,
we
describe
potential
influencing
vulnerability
stress,
budding
causative
Alzheimer's
Parkinson's
disease.
Secondly,
contributing
roles
been
observed
attenuating
inflammation
via
its
own
or
by
producing
secondary
and,
modulation
population
antioxidative
anti-inflammatory
probiotics
have
shown
promising
neuro
resilience.
Thirdly,
high
throughput
silico
tools
databases
correlation
microbiome,
health,
thus
providing
fascinating
perspective
new
avenues
for
therapeutic
options.
FEMS Microbiology Reviews,
Год журнала:
2023,
Номер
47(4)
Опубликована: Июль 1, 2023
Abstract
In
humans,
many
diseases
are
associated
with
alterations
in
gut
microbiota,
namely
increases
or
decreases
the
abundance
of
specific
bacterial
groups.
One
example
is
genus
Faecalibacterium.
Numerous
studies
have
underscored
that
low
levels
Faecalibacterium
correlated
inflammatory
conditions,
bowel
disease
(IBD)
forefront.
Its
representation
also
diminished
case
several
diseases,
including
colorectal
cancer
(CRC),
dermatitis,
and
depression.
Additionally,
relative
presence
this
considered
to
reflect,
at
least
part,
intestinal
health
status
because
frequently
present
reduced
individuals
gastrointestinal
disorders.
review,
we
first
thoroughly
describe
updates
taxonomy
Faecalibacterium,
which
has
transformed
a
single-species
taxon
multispecies
over
last
decade.
We
then
explore
links
discovered
between
various
since
IBD-focused
were
published.
Next,
examine
current
available
strategies
for
modulating
gut.
Finally,
summarize
mechanisms
underlying
beneficial
effects
been
attributed
genus.
Together,
epidemiological
experimental
data
strongly
support
use
as
next-generation
probiotic
(NGP)
live
biotherapeutic
product
(LBP).
Frontiers in Aging Neuroscience,
Год журнала:
2021,
Номер
13
Опубликована: Фев. 12, 2021
Patients
with
Parkinson's
disease
(PD)
were
often
observed
gastrointestinal
symptoms,
which
preceded
the
onset
of
motor
symptoms.
Neuropathology
PD
has
also
been
found
in
enteric
nervous
system
(ENS).
Many
studies
have
reported
significant
PD-related
alterations
gut
microbiota.
This
meta-analysis
was
performed
to
evaluate
differences
microbiota
between
patients
and
healthy
controls
(HCs)
across
different
geographical
regions.
We
conducted
a
systematic
online
search
for
case-control
detecting
HCs.
Mean
difference
(MD)
95%
confidence
interval
(CI)
calculated
access
abundance
certain
families
PD.
Fifteen
included
this
study.
Our
results
showed
lower
levels
Prevotellaceae
(MD
=
−0.37,
CI
−0.62
−0.11),
Faecalibacterium
−0.41,
CI:
−0.57
−0.24),
Lachnospiraceae
−0.34,
−0.59
−0.09)
compared
Significant
higher
level
Bifidobacteriaceae
0.38,
95%;
0.12
0.63),
Ruminococcaceae
0.58,
0.07
1.10),
Verrucomicrobiaceae
0.45,
0.21
0.69),
Christensenellaceae
0.20,
0.34)
Thus,
shared
detected
These
dysbiosis
might
lead
impairment
short-chain
fatty
acids
(SCFAs)
producing
process,
lipid
metabolism,
immunoregulatory
function,
intestinal
permeability,
contribute
pathogenesis
Short-chain
fatty
acids
(SCFAs)
are
gut
microbial
metabolites
that
promote
the
disease
process
in
a
rodent
model
of
Parkinson
(PD),
but
fecal
levels
SCFAs
patients
with
PD
reduced.
Simultaneous
assessments
plasma
SCFA
levels,
their
interrelationships
process,
scarce.
We
aimed
to
compare
different
subtypes
healthy
controls
delineate
interrelations
link
microbiota
changes
clinical
severity
PD.
Methods
A
cohort
96
85
were
recruited
from
National
Taiwan
University
Hospital.
Fecal
concentrations
measured
using
chromatography
mass
spectrometry.
Gut
was
analyzed
metagenomic
shotgun
sequencing.
Body
index
medical
comorbidities
evaluated
dietary
information
obtained
food
frequency
questionnaire.
To
assess
motor
cognitive
impairment,
we
used
Movement
Disorder
Society–Unified
Parkinson9s
Disease
Rating
Scale
(MDS-UPDRS)
Mini-Mental
Status
Examination
(MMSE).
Results
Compared
controls,
had
lower
higher
acetate,
propionate,
butyrate.
After
adjustment
for
age,
sex,
duration,
anti-PD
medication
dosage,
MDS-UPDRS
part
III
scores
correlated
reduced
acetate
(ρ
=
−0.37,
p
0.012),
propionate
−0.32,
0.036),
butyrate
−0.40,
0.004)
increased
0.26,
0.042)
MMSE
negatively
−0.09,
0.027)
valerate
−0.032,
0.033)
after
confounders.
SCFAs-producing
bacteria
positively
revealed
no
association
In
patient
group,
abundance
proinflammatory
microbes,
such
as
Clostridiales
bacterium
NK3B98Ruminococcus
sp
AM07-15,
significantly
decreased
SCFAs,
especially
propionic
acid.
Discussion
Reductions
observed
corelated
specific
Classification
Evidence
This
study
provides
Class
evidence
metabolite
distinguish
between
associated
Biomedicines,
Год журнала:
2022,
Номер
10(2), С. 436 - 436
Опубликована: Фев. 13, 2022
Dopamine
is
a
neurotransmitter
that
plays
critical
role
both
peripherally
and
centrally
in
vital
functions
such
as
cognition,
reward,
satiety,
voluntary
motor
movements,
pleasure,
motivation.
Optimal
dopamine
bioavailability
essential
for
normal
brain
functioning
protection
against
the
development
of
neurological
diseases.
Emerging
evidence
shows
gut
microbiota
have
significant
roles
maintaining
adequate
concentrations
via
intricate,
bidirectional
communication
known
microbiota-gut-brain
axis.
The
vagus
nerve,
immune
system,
hypothalamus-pituitary-adrenal
axis,
microbial
metabolites
serve
important
mediators
reciprocal
signaling.
Furthermore,
contain
intrinsic
enzymatic
activity
highly
involved
metabolism,
facilitating
synthesis
well
its
metabolite
breakdown.
This
review
examines
relationship
between
key
genera
Prevotella,
Bacteroides,
Lactobacillus,
Bifidobacterium,
Clostridium,Enterococcus,
Ruminococcus
their
effects
on
dopamine.
dysbiosis
subsequent
impact
dopamine-related
pathological
conditions
Parkinson's
disease
are
also
discussed.
Understanding
modulating
periphery
central
nervous
system
can
help
identify
new
therapeutic
targets
optimize
available
methods
to
prevent,
delay,
or
restore
dopaminergic
deficits
neurologic
metabolic
disorders.